Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Genetic Studies of Chronic Active Epstein-Barr Disease

View source ↗

Summary

This clinical trial update details genetic studies investigating Chronic Active Epstein-Barr virus infection, sponsored by NIAID, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Active Epstein-Barr Virus | Status: RECRUITING